Skip to main content
RecallFDAfda-F-1154-2022UNDECLARED ALLERGEN

SUPPLE BEARS QUERCETIN BROMELAIN GUMMIES + Vitamin C & Zinc 60 DIETARY SUPPLEMENTS NO SOY, NO GLUTEN, NO EGGS, NO DIARY, NO NUTS, NO GELA...

Category
Units Affected
62
Recall Date
May 5, 2022
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1154-2022.

Product was labeled as "gluten free" and it may contain gluten.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1154-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact 6174 Industries, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1154-2022.

6174 Industries, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

6174 Industries, Llc Recall FAQ

6174 Industries, Llc is the subject of a supplements safety report: SUPPLE BEARS QUERCETIN BROMELAIN GUMMIES + Vitamin C & Zinc 60 DIETARY SUPPLEMENTS NO SOY, NO GLUTEN, NO EGGS, NO DIARY, NO NUTS, NO GELA.... The notice was published on May 5, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 62 units are potentially affected.